Bruce Robb, MD
Colon & Rectal Surgery · Indianapolis, INNPI 1053362137
Payments from drug & device makers
What this record shows
Intuitive Surgical accounts for 80.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,000 and has fallen 83.2% since, to $168 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in IN, where the typical reported total is $1,741.
Across 10 payments — averaging $150.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Johnson & Johnson$148
- Conmed Corporation$129
- Medical Device Business Services, Inc.$21
Across 7 payments — averaging $23,408 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$137K
- Takeda Pharmaceuticals U.S.A., Inc.$27K
What the payments were for
- Travel & lodging$85056%
- Food & beverage$65944%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $1,210 |
| Johnson & Johnson | 1 | $148 |
| Conmed Corporation | 1 | $129 |
| Medical Device Business Services, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,085
- Echelon Circular$148
- AIRSEAL$129
How this compares
$1,508 in reported general payments places this provider in the 45th percentile of 54 colon & rectal surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Opium Tincture | 27 | $9,643 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 25 | $1,952 |
| Mupirocin | 54 | $433 |
| Neomycin Sulfate | 82 | $432 |
| Oxycodone Hcl | 33 | $358 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $225 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $133 |
| Metronidazole | 81 | $110 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Indianapolis
- Shekar NarayananIndianapolis$67K
- Sanjay MohantyIndianapolis$11K
- Nikhil PatelIndianapolis$7K
- Frederick LaneIndianapolis$4K
- Arun GowdamarajanIndianapolis$4K
- Sarah JochumIndianapolis$4K
- Sanjay ThekkeurumbilIndianapolis$3K
- Patrick WhiteIndianapolis$3K
- Ateet ShahIndianapolis$2K
- Peter DavisIndianapolis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.